RT Journal Article
SR Electronic
T1 Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 136
DO 10.1186/s40425-019-0599-8
VO 7
IS 1
A1 Stein, Mark N.
A1 Malhotra, Jyoti
A1 Tarapore, Rohinton S.
A1 Malhotra, Usha
A1 Silk, Ann W.
A1 Chan, Nancy
A1 Rodriguez, Lorna
A1 Aisner, Joseph
A1 Aiken, Robert D.
A1 Mayer, Tina
A1 Haffty, Bruce G.
A1 Newman, Jenna H.
A1 Aspromonte, Salvatore M.
A1 Bommareddy, Praveen K.
A1 Estupinian, Ricardo
A1 Chesson, Charles B.
A1 Sadimin, Evita T.
A1 Li, Shengguo
A1 Medina, Daniel J.
A1 Saunders, Tracie
A1 Frankel, Melissa
A1 Kareddula, Aparna
A1 Damare, Sherrie
A1 Wesolowsky, Elayne
A1 Gabel, Christian
A1 El-Deiry, Wafik S.
A1 Prabhu, Varun V.
A1 Allen, Joshua E.
A1 Stogniew, Martin
A1 Oster, Wolfgang
A1 Bertino, Joseph R.
A1 Libutti, Steven K.
A1 Mehnert, Janice M.
A1 Zloza, Andrew
YR 2019
UL http://jitc.bmj.com/content/7/1/136.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.